fda warning bpc 157 safety cancer BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded FDA scientists flag concerns with
Description
Both the obstruction of peritubular capillaries in damaged glomeruli and an imbalance of vasoactive substances (activation of renin-angiotensin system, endothelin, etc.) will result in a downstream decrease in tubulointerstitial blood flow

0.5 mL : Ideal for doses between 30 to 50 units
It is also more common in older adults, as the bodys ability to absorb vitamin B12 from food decreases with age

Even if BPC-157 survives gastric acid, pepsin and pancreatic proteases remain active in the duodenum and small intestine at physiological pH and will hydrolyze unprotected peptide bonds
